Generation Bio, one of a handful of biotechnology companies pursuing promising gene therapy treatments in the Boston region, is planning to scale up production after securing space for a planned manufacturing facility in Waltham, Massachusetts.
Generation Bio Secures Waltham Manufacturing Site
Biotechnology Company Signs 12-Year Lease in CenterPoint Complex
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- CenterPoint
41 Seyon St, Waltham, MA
- Companies
- Generation Bio
Professional, Scientific, and Technical Services
- Saracen Properties
Real Estate
- Contacts
- Matthew Malatesta
Senior Managing Director, Newmark
- Mark Roth
Managing Director, The Wingate Companies
- David Townsend
Executive Managing Director, Newmark
- Brendan Daly
Managing Director